Cleveland Jewish News: William Schiemann, associate professor of general medical sciences, led a team of researchers who found a link between a micro ribonucleic acid molecule and late-stage breast cancer. “Our micro RNA inactivates [a protein called] Bim, and we think this leads to chemo resistance to these metastatic cancers,” Schiemann said. Lower Bim levels, coupled with higher miR-181a levels, allow the spread of cancer.
Medicine’s William Schiemann and researchers target molecule’s role in late-stage breast cancer
- Center on Urban Poverty and Community Development researchers write about lead exposure
- PBS documentary to showcase Violins of Hope
- Law’s Jonathan Adler comments on Supreme Court Chief Justice John Roberts’ plans to limit the role of courts
- Eat pizza with Provost Baeslack, learn about new university initiatives today
- CWRU alumnus to take the field for Super Bowl 50